Bank of New York Mellon’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-99,890
Closed -$12K 4206
2024
Q4
$12K Hold
99,890
﹤0.01% 4108
2024
Q3
$13.7K Buy
99,890
+1
+0% ﹤0.01% 4076
2024
Q2
$14.6K Hold
99,889
﹤0.01% 4091
2024
Q1
$14.6K Sell
99,889
-336,256
-77% -$47K ﹤0.01% 4121
2023
Q4
$87.3K Buy
436,145
+1
+0% ﹤0.01% 4111
2023
Q3
$72.9K Hold
436,144
﹤0.01% 4127
2023
Q2
$87.2K Sell
436,144
-144,247
-25% -$29.3K ﹤0.01% 4102
2023
Q1
$123K Hold
580,391
﹤0.01% 4041
2022
Q4
$94.6K Sell
580,391
-1,127
-0.2% -$231 ﹤0.01% 4125
2022
Q3
$123K Hold
581,518
﹤0.01% 4159
2022
Q2
$128K Sell
581,518
-992
-0.2% -$253 ﹤0.01% 4182
2022
Q1
$196K Sell
582,510
-363,047
-38% -$119K ﹤0.01% 4249
2021
Q4
$290K Buy
945,557
+378,984
+67% +$171K ﹤0.01% 4106
2021
Q3
$297K Buy
566,573
+146,366
+35% +$86.4K ﹤0.01% 4041
2021
Q2
$350K Sell
420,207
-58,104
-12% -$54.1K ﹤0.01% 3917
2021
Q1
$756K Buy
+478,311
New +$782K ﹤0.01% 3486
2019
Q2
Sell
-72,880
Closed -$25K 4319
2019
Q1
$25K Hold
72,880
﹤0.01% 4149
2018
Q4
$90K Hold
72,880
﹤0.01% 3979
2018
Q3
$136K Buy
72,880
+1,737
+2% +$3.72K ﹤0.01% 3994
2018
Q2
$160K Buy
+71,143
New +$143K ﹤0.01% 3942

Other funds holding ZOM

Bank of New York Mellon's ZOM Position: Q1 2025 in Review

Bank of New York Mellon sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 99,890 shares — an estimated $12K sold.

Bank of New York Mellon first reported a position in ZOM in Q2 2018 and held it in 20 quarters. The position peaked at $756K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Bank of New York Mellon reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 99,890 Zomedica Corp. shares in Q1 2025, an estimated $12K.
  • Bank of New York Mellon first reported a position in Zomedica Corp. in Q2 2018 and held it in 20 quarters.
  • Bank of New York Mellon's Zomedica Corp. position peaked at $756K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Bank of New York Mellon's 13F filing for Q1 2025, filed 29 Apr 2025.